Sphera Funds Management Ltd. Chemomab Therapeutics Ltd. Transaction History
Sphera Funds Management Ltd.
- $545 Million
- Q3 2024
A detailed history of Sphera Funds Management Ltd. transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 1,214,575 shares of CMMB stock, worth $2.6 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
1,214,575Holding current value
$2.6 Million% of portfolio
0.35%Shares
1 transactions
Others Institutions Holding CMMB
# of Institutions
19Shares Held
4.57MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA1.74MShares$3.73 Million0.06% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3810KShares$1.73 Million0.21% of portfolio
-
Morgan Stanley New York, NY402KShares$860,8620.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$456,6580.06% of portfolio
-
Two Sigma Securities, LLC New York, NY39.9KShares$85,4690.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $24.5M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...